The Ministry of Health, Labor and Welfare (MHLW) on November 29 proposed a more stringent application of the current 40% entry price rule for first oral generics towards the FY2024 drug pricing reform.Under the current rule, first oral generics are…
HOME > REGULATORY
REGULATORY
- MHLW Announces Additional Indications for 3 APIs Following Prior Assessments
November 7, 2011
- CSIMC Approves Plan to Ban Use of “Dispensing Point” Cards by Pharmacies, Drugstores
November 4, 2011
- CSIMC Subcommittee Approves Proposal to Expand Range of Drugs Subject to Re-pricing
November 4, 2011
- Japan, China, S. Korea Agree to Draft GL on Joint Clinical Trials
November 2, 2011
- Chuikyo Subcommittee Approves Proposal to Expand Range of Drugs Subject to Re-pricing
November 2, 2011
- Chuikyo Approves Plan to Ban Use of “Dispensing Point” Cards by Pharmacies, Drugstores
November 2, 2011
- Committee Recommends Approval of 3 Products Including MSD’s Rota Teq
November 1, 2011
- Business Sector Call for Japan to Join TPP Talks Voiced at National Strategy Council Meeting
November 1, 2011
- Korosho to Ask Doctors to Exercise Caution in Co-prescribing 3 or More Psychotropics
November 1, 2011
- Healthcare Reps at Chuikyo Call For Quality Assurance to Promote GE Use
November 1, 2011
- WT of DPJ Begins Discussion, Not Yet Known If It Covers Drug Pricing System
October 31, 2011
- Medical Benefits Rose 4.2% in FY2009, Breaking ¥30 Tril. for 1st Time
October 31, 2011
- Drug-induced Hepatitis Victims, Lawyers Petition Against Establishment of “Third Party Organization”
October 31, 2011
- MHLW Research Team Looks Into Compliance Systems, Gathering Advanced Case Studies
October 28, 2011
- CSIMC's Drug Price Committee Agrees to Review Foreign Price-Based Adjustments, Increase Downward Revising
October 28, 2011
- MHLW Varies Direction of Revision with Innovative Evaluation and Efficiency
October 28, 2011
- MHLW Calls for Package Insert Revisions for 6 Products Including Strattera
October 28, 2011
- US FDA Extends Action Date for SGLT-2 Inhibitor Dapagliflozin
October 28, 2011
- Mr Yoshimura of Astem to Be Named as Successor of Mr Matsutani: CSIMC Expert Member
October 28, 2011
- Drug-induced Hepatitis Victims Petition Against Creation of Korosho-Proposed “Third-Party Organization”
October 28, 2011
ページ
Referrals can be an absolute game-changer in recruitment.When someone in your network recommends a candidate, they often have firsthand insight into the person’s skills, work ethic, values and ambitions. This insider knowledge results in higher quality candidates who are a…
Chugai Pharmaceutical’s Phesgo (pertuzumab + trastuzumab + vorhyaluronidase alfa) and Novartis’ Leqvio (inclisiran) will be newly added to the Japanese reimbursement list along with a batch of other medicines on November 22. Three drugs carry peak sales outlooks of over…
The main players in the FY2024 reimbursement policy reform are now all in place, with the roster rounded out by the appointment of former health minister Katsunobu Kato for the Liberal Democratic Party’s (LDP) prominent social security post at the…
A member of the Ministry of Health, Labor and Welfare’s (MHLW) study group on the generic industry on November 13…
A health ministry study group on pharmaceutical regulations on October 13 roughly agreed on a reform plan for Japanese regulatory…
The Japanese health ministry’s expert panel tasked to discuss comprehensive policies for the rapid and stable supply of pharmaceuticals generally…
A key Japanese reimbursement policy panel on December 16 approved the government-backed plan for the FY2023 “off-year” drug price revision.…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…